Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel With or Without Thalidomide in Metastatic Prostate Cancer
NCT00020046Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in prostate cancer (PCa), sponsored by National Institutes of Health. Started Dec 1999; status: completed.
02
Drugs
thalidomide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00020046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020046.